drugset / Trial / NCT00880750

Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults

NCT00880750

Phase 1 Completed 72 enrolled Shire
RandomizedCrossoverOpen-labelOther

Summary

This study is being conducted to assess any potential differences in the absorption and excretion between two lanthanum carbonate formulations. This study is also being done to assess the safety and tolerability of the two lanthanum carbonate formulations.

Timeline

Start
2009-01-28
Primary completion
2009-06-22
Completion
2009-06-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Lanthanum Carbonate Other / unclassified 1000 mg Oral